Clinical trialNCT05634369RecruitingPhase 1/PHASE2Interventional

A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue

SponsorNationwide Children's HospitalEnrollment50Pediatric Sarcoma, RefractoryPediatric Sarcoma, Relapsed

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Bhuvana Setty, MD
Nationwide Children's Hospital
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Alabama
South Birmingham, Alabama, United States
Elizabeth Alva, MD
Recruiting
Phoenix Children'S Hospital
Phoenix, Arizona, United States
Mona Nourani, MD
Recruiting
Arkansas Children'S Hospital
Little Rock, Arkansas, United States
David Douglas, MD
Recruiting
Children'S Hospital of Los Angeles
Los Angeles, California, United States
Fariba Navid, MD
Recruiting
Stanford University
Palo Alto, California, United States
Raya Hamad Saab, MD
Recruiting
University of Florida
Gainesville, Florida, United States
John Ligon, MD
Recruiting
Nemours Jacksonville
Jacksonville, Florida, United States
Anderson Collier, III, MD
Recruiting
University of Miami
Miami, Florida, United States
Aditi Dhir, MD
Recruiting
Johns Hopkins All Children'S Hospital
St. Petersburg, Florida, United States
Natalie Booth, DO
Recruiting
Washington University/st Louis Childrens
St Louis, Missouri, United States
Amy Armstrong, MD
Recruiting
Roswell Park Comprehensive Cancer Center
Buffalo, New York, United States
Ajay Gupta, MD
Recruiting
Montefiore Medical Center
The Bronx, New York, United States
Alice Lee, MD
Recruiting
University of North Carolina
Chapel Hill, North Carolina, United States
Patrick Thompson, MD
Recruiting
Levine Cancer Institute
Charlotte, North Carolina, United States
Erin M Trovillion, MD
Recruiting
Duke Children'S Hospital/duke Health
Durham, North Carolina, United States
Jessica Sun, MD
Recruiting
Cleveland Clinic
Cleveland, Ohio, United States
Matteo Trucco, MD
Recruiting
Nationwide Children'S Hospital
Columbus, Ohio, United States
Bhuvana Setty, MD
Recruiting
Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Jacquelyn W Crane, MD
Recruiting
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Scott Borinstein, MD
Recruiting
Ut Southwestern
Dallas, Texas, United States
Avanthi Shah, MD
Recruiting
University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Irtiza Sheikh, MDJonathan Gill, MD
Recruiting
Primary Children'S Hospital
Salt Lake City, Utah, United States
Matthew Dietz, DO
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 14 Nov 2022
Primary completion: 1 Dec 2026
Completion: 1 Dec 2027
Last update posted: 28 Jan 2026
Registered enrollment: 50
Registry id: NCT05634369

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.